ストックスクリーナーアプリを入手
0.043
9,900%
0.0425
アフターアワーズ：
.04
-0.003
-6.98%
前日終値:
$0.0005
開ける：
$0.043
24時間の取引高:
182
Relative Volume:
66.00
時価総額：
$N/A
収益：
-
当期純損益:
$-66.00M
株価収益率:
-0.0811
EPS:
-0.53
ネットキャッシュフロー:
$-60.55M
1週間 パフォーマンス:
+9,900%
1か月 パフォーマンス:
-87.90%
6か月 パフォーマンス:
-95.00%
1年 パフォーマンス:
-97.29%
1日の値動き範囲:
$0.043
$0.043
1週間の範囲:
$0.043
$0.043
52週間の値動き範囲:
$0.043
$0.043
Vaxxinity Inc Stock (VAXX) Company Profile
VAXX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VAXX
Vaxxinity Inc
|
0.043 | 0 | 0 | -66.00M | -60.55M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.55 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.31 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.83 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
762.89 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.93 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
Vaxxinity Inc Stock (VAXX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-08 | 開始されました | Robert W. Baird | Outperform |
| 2022-04-27 | 開始されました | Evercore ISI | In-line |
Vaxxinity Inc (VAXX) 最新ニュース
Dallas District Court Split in High-Stakes Stock Dispute - Inforney News
Local Man Arrested on Multiple Charges, Including Drug Delivery and Bribery - Inforney News
Top 6 Healthcare Stock Picks in 2025 - timothysykes.com
Hypercholesterolemia Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com
Hypercholesterolemia Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight - Menafn.com
Head to Head Contrast: ANI Pharmaceuticals (NASDAQ:ANIP) vs. Vaxxinity (NASDAQ:VAXX) - Defense World
Forney ISD Issues RFP for Security Guard Services Purchasing Contract Starting July 1 2025 - Inforney News
Crime Stoppers Most Wanted- Jose Raudel Muro-Ortega - Inforney News
Forney Hospital Project Set to Transform City Landscape - Inforney News
Vaccinex plans Nasdaq exit as Alzheimer market pressure grows - Pharmaceutical Technology
New Costco in Forney to Feature $3.5M Fuel Station - Inforney News
BJ's Coming to Forney with $10 Million Dollar Build at Hwy 80 & Gateway - Inforney News
Starbucks in Kroger Set for Remodel This Summer - Inforney News
Burlington to Open a New 22,000 Sq Ft Store at Village at Gateway, Expected to Welcome Shoppers by Early 2026 - Inforney News
Forney Costco Construction Updates: Breaking Ground In April, Won't Open Before TXDOT Bridge Completes - Inforney News
Governors Small Business Summit KaufmanA Sold Out Event - Inforney News
Texas Board Of Education Approves Optional Bible Curriculum In Public Schools - Inforney News
Kaufman's Community Economic Development Award - Inforney News
How a new kind of vaccine could lead to the eradication of Alzheimer's and dementia - New Scientist
Vaxxinity - The Pharma Letter
Study: Therapeutic Parkinson's vaccine safely inhibits alpha-synuclein clumps - Parkinson's News Today
Parkinson's Prevention May Include Tetanus Vaccination - Vax-Before-Travel
Vaxxinity’s Immunotherapy Meets Phase I Goals in Parkinson’s Patients - Inside Precision Medicine
A Potential Parkinson’s Treatment Has Promising Results - Time Magazine
Kaufman County and TXDOT Propose New Outer LoopPublic Input Session - Inforney News
Vaxxinity leaders detail retreat from 'abusive relationship' after 3 years on public market - Fierce Biotech
Terrell Breaks Ground On Northspur Development - Inforney News
Vaxxinity, Inc. (VAXX) Perplexes All, Surges 44% Amidst Delisting Decision - 富途牛牛
What's Driving These Stocks Higher In After-hours? - RTTNews
Why Is Vaxxinity (VAXX) Stock Down 58% Today? - TradingView
Vaxxinity to voluntarily delist from Nasdaq - Investing.com
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting - GlobeNewswire
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates - Yahoo Finance
Vaxxinity Inc Motivates Team with Option Repricing Initiative - TipRanks
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial - ScienceAlert
AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine - Pharmaceutical Technology
Vaxxinity reports breakthrough in Parkinson's treatment By Investing.com - Investing.com UK
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published - GlobeNewswire
Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024 - GlobeNewswire
Vaxxinity, University of Florida join for work on Parkinson’s vaccine - Parkinson's News Today
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida - Yahoo Finance
Vaxxinity Wants to Bring Accessible Vaccines for Chronic Illness to Market - cheddar.com
Vaxxinity, University of Central Florida launch collaboration to advance medicines for use in space - Fierce Biotech
Vaccines show promise against common chronic diseases - Gavi, the Vaccine Alliance
Vaxxinity making vaccines to change the world - Labiotech.eu
Researchers return to Alzheimer's vaccines, buoyed by recent drug success - Reuters
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewswire
Mei Mei Hu - The World Economic Forum
Rene Paula - Columbia Law School
Pursuing A "Biologic Revolution" With Vaxxinity's Mei Mei Hu - Bioprocess Online
Area fire departments fighting large grass fire north of Forney - Inforney News
Vaxxinity Inc (VAXX) 財務データ
収益
当期純利益
現金流量
EPS
0.88%
0.76%
大文字化:
|
ボリューム (24 時間):